ITPR2 (Q14571) variants and mutations
ITPR2 (also known as Q14571) is a human protein-coding gene encoding an inositol 1,4,5-trisphosphate-gated calcium channel protein. Its annotated function is inositol 1,4,5-trisphosphate-gated calcium channel that upon inositol 1,4,5-trisphosphate binding transports calcium from the endoplasmic reticulum lumen to cytoplasm. Exists in two states; a long-lived closed state where the channel is…. It is annotated at the endoplasmic reticulum membrane. This analysis covers 2,736 ITPR2 variants and mutations. Of these, 71% have computational variant effect predictions. Disease context includes isolated anhidrosis with normal sweat glands, alcohol drinking, and atrial fibrillation. Example ITPR2 variants include M1?, T2I, and E3D.
Variant analysis overview
- Gene: ITPR2
- Protein: Q14571
- UniProt accession: Q14571
- Organism: Homo sapiens
- Variants analyzed: 2736
- Variant scope: all variants
- Completed: 2026-09-02
Variant and mutation evidence
- Variant composition: 2,540 unspecified-consequence records; 85 synonymous variants; 90 missense variants; 10 frameshift variants; 8 stop-gained variants; 3 in-frame deletions; 1 splice-region variants
- Prediction scores: 1,949 variants have prediction scores (71% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: isolated anhidrosis with normal sweat glands, alcohol drinking, atrial fibrillation, open-angle glaucoma, familial hypercholesterolemia, clonal hematopoiesis, diabetes mellitus, refractive error, Abnormality of refraction, tooth disorder, crystal arthropathy, urolithiasis.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 5 domains; 28 binding sites; 6 post-translational modification sites.
- Structural context: 357 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable ITPR2 variants
Examples include M1?, T2I, E3D, K4N, S7N, S7R, L9F, Y10C. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA Cosmic COSV5438, NCI-TCGA Cosmic COSV9965, cosmic curated COSV99659, Variant assessed as somatic; high impact.
- T2I (p.Thr2Ile), Ensembl rs1565795822, REVEL 0.21, CADD 24.20
- E3D (p.Glu3Asp), TOPMed rs1289532251, gnomAD rs1289532251, REVEL 0.30, CADD 13.10
- K4N (p.Lys4Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S7N (p.Ser7Asn), ExAC rs756770478, TOPMed rs756770478, gnomAD rs756770478, REVEL 0.45, CADD 23.20
- S7R (p.Ser7Arg), ExAC rs751052733, gnomAD rs751052733, REVEL 0.67, CADD 25.40
- L9F (p.Leu9Phe), ExAC rs764087651, gnomAD rs764087651
- Y10C (p.Tyr10Cys), Ensembl rs1951138224, REVEL 0.64, CADD 29.40
- I11M (p.Ile11Met), TOPMed rs1371793048, gnomAD rs1371793048, REVEL 0.60, CADD 22.60
- I11T (p.Ile11Thr), Ensembl rs1951138084, REVEL 0.66, CADD 24.60
- I11V (p.Ile11Val), ExAC rs758241063, TOPMed rs758241063, gnomAD rs758241063, REVEL 0.40, CADD 23.60
- D13E (p.Asp13Glu), gnomAD rs1243326320, REVEL 0.89, CADD 25.00
- D13G (p.Asp13Gly), cosmic curated COSV54383, ExAC rs752590283, gnomAD rs752590283, REVEL 0.95, CADD 32.00
- D13H (p.Asp13His), TOPMed rs1356550882, gnomAD rs1356550882
- D13N (p.Asp13Asn), TOPMed rs1356550882, gnomAD rs1356550882, REVEL 0.78, CADD 24.10
- D13Y (p.Asp13Tyr), TOPMed rs1356550882, gnomAD rs1356550882, REVEL 0.93, CADD 28.90
- I14M (p.Ile14Met), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54387, Variant assessed as somatic; moderate impact.
- I14T (p.Ile14Thr), gnomAD rs1421561422, REVEL 0.89, CADD 29.30
- V15A (p.Val15Ala), TOPMed rs1951137512
- V15M (p.Val15Met), TOPMed rs1182115304, gnomAD rs1182115304, REVEL 0.75, CADD 26.50
- S16C (p.Ser16Cys), gnomAD rs1476004438, REVEL 0.87, CADD 31.00
- S16F (p.Ser16Phe), rs1476004438, NCI-TCGA Cosmic COSV5438, cosmic curated COSV54385, gnomAD rs1476004438, REVEL 0.92, CADD 32.00, Variant assessed as somatic; moderate impact.
- A19G (p.Ala19Gly), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A19T (p.Ala19Thr), Ensembl rs754511276, REVEL 0.72, CADD 25.20
- A19V (p.Ala19Val), TOPMed rs1565795763, gnomAD rs1565795763, REVEL 0.63, CADD 27.80
- E20G (p.Glu20Gly), TOPMed rs1266844865, gnomAD rs1266844865, REVEL 0.83, CADD 33.00
- N24S (p.Asn24Ser), rs2230371, ClinGen CA6490220, ClinVar RCV000968684, 1000Genomes rs2230371, REVEL 0.33, CADD 22.00, Likely benign, not provided
- G25C (p.Gly25Cys), Ensembl rs2137322082
- S28I (p.Ser28Ile), NCI-TCGA TCGA novel, REVEL 0.84, CADD 26.60, Variant assessed as somatic; moderate impact.
- V38L (p.Val38Leu), Ensembl rs1950319428
- V39M (p.Val39Met), Ensembl rs1950319383, REVEL 0.83, CADD 25.80
- H40R (p.His40Arg), gnomAD rs551315529, REVEL 0.34, CADD 21.90
- P41S (p.Pro41Ser), Ensembl rs1950319168
- E42* (p.Glu42Ter), NCI-TCGA Cosmic COSV5438, NCI-TCGA Cosmic COSV9965, cosmic curated COSV99659, Variant assessed as somatic; high impact.
- E42K (p.Glu42Lys), rs1385731545, NCI-TCGA Cosmic COSV5438, cosmic curated COSV54383, NCI-TCGA Cosmic COSV9965, REVEL 0.62, CADD 22.30, Variant assessed as somatic; moderate impact.
- A43S (p.Ala43Ser), ExAC rs762104225, gnomAD rs762104225
- A43T (p.Ala43Thr), ExAC rs762104225, gnomAD rs762104225, REVEL 0.44, CADD 22.20
- G44W (p.Gly44Trp), gnomAD rs1950318864, REVEL 0.87, CADD 27.00
- D45N (p.Asp45Asn), TOPMed rs1164263542, gnomAD rs1164263542, REVEL 0.53, CADD 22.90, Uncertain significance, not specified
- D45Y (p.Asp45Tyr), TOPMed rs1164263542, gnomAD rs1164263542, Uncertain significance
- N48K (p.Asn48Lys), TOPMed rs1178910616, gnomAD rs1178910616, REVEL 0.61, CADD 23.20
- N48S (p.Asn48Ser), gnomAD rs1405639825
- K51E (p.Lys51Glu), gnomAD rs1365162363, REVEL 0.76, CADD 28.80
- K51N (p.Lys51Asn), ExAC rs764111261, TOPMed rs764111261, gnomAD rs764111261
- K52* (p.Lys52Ter), TOPMed rs1950318480
- L57F (p.Leu57Phe), gnomAD rs1297505737, REVEL 0.95, CADD 28.10
- V60M (p.Val60Met), Ensembl rs1303530107
- C61Y (p.Cys61Tyr), 1000Genomes rs571177431, ExAC rs571177431, TOPMed rs571177431, gnomAD rs571177431, REVEL 0.80, CADD 24.30
- P62S (p.Pro62Ser), TOPMed rs1948908609
- M63V (p.Met63Val), rs749938688, ClinGen CA234840097, ClinVar RCV004259151, TOPMed rs749938688, REVEL 0.81, CADD 22.60, Uncertain significance, not specified
- N64S (p.Asn64Ser), ExAC rs752814982, TOPMed rs752814982, gnomAD rs752814982, REVEL 0.55, CADD 22.30
- Q71E (p.Gln71Glu), TOPMed rs1948908197, gnomAD rs1948908197, REVEL 0.82, CADD 25.30
- K74I (p.Lys74Ile), ExAC rs777078064, gnomAD rs777078064, REVEL 0.88, CADD 29.60
- A75S (p.Ala75Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- A75T (p.Ala75Thr), TOPMed rs972966180, REVEL 0.74, CADD 24.20
- Q77H (p.Gln77His), gnomAD rs1185726988, REVEL 0.62, CADD 22.60
- A78V (p.Ala78Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K79T (p.Lys79Thr), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99659, Variant assessed as somatic; moderate impact.
- N82K (p.Asn82Lys), TOPMed rs1423510840, gnomAD rs1423510840, REVEL 0.37, CADD 19.00
- T84I (p.Thr84Ile), gnomAD rs1305436442, REVEL 0.76, CADD 25.20
- T84N (p.Thr84Asn), gnomAD rs1305436442, REVEL 0.58, CADD 23.40
- E85A (p.Glu85Ala), gnomAD rs1948907411, REVEL 0.66, CADD 24.10
- E85K (p.Glu85Lys), cosmic curated COSV54384, TOPMed rs1190602890, gnomAD rs1190602890, REVEL 0.49, CADD 23.40
- A87T (p.Ala87Thr), cosmic curated COSV54386, gnomAD rs1948907356, REVEL 0.58, CADD 22.70
- A87V (p.Ala87Val), TOPMed rs1482240966, gnomAD rs1482240966, REVEL 0.41, CADD 20.40, Uncertain significance, not specified
- K90R (p.Lys90Arg), ExAC rs772754580, gnomAD rs772754580, REVEL 0.63, CADD 24.50
- H94R (p.His94Arg), TOPMed rs1392674004
- A96S (p.Ala96Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E97* (p.Glu97Ter), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54384, CADD 40.00, Variant assessed as somatic; high impact.
- E97K (p.Glu97Lys), cosmic curated COSV10502, ExAC rs766813958, TOPMed rs766813958, gnomAD rs766813958, REVEL 0.71, CADD 27.30
- E97Q (p.Glu97Gln), ExAC rs766813958, TOPMed rs766813958, gnomAD rs766813958
- K101R (p.Lys101Arg), 1000Genomes rs150639698, ESP rs150639698, ExAC rs150639698, TOPMed rs150639698, REVEL 0.70, CADD 26.40
- Q102E (p.Gln102Glu), Ensembl rs1948891372
- E104Q (p.Glu104Gln), ESP rs369326833, TOPMed rs369326833, gnomAD rs369326833, REVEL 0.68, CADD 26.20
- S105L (p.Ser105Leu), rs767122062, ClinGen CA6490152, cosmic curated COSV54386, ClinVar RCV004093309, REVEL 0.66, CADD 25.00, Uncertain significance, not specified
- S105P (p.Ser105Pro), ExAC rs773624105, gnomAD rs773624105, REVEL 0.59, CADD 22.40
- K108E (p.Lys108Glu), ExAC rs773831925, gnomAD rs773831925, REVEL 0.36, CADD 22.80
- G112E (p.Gly112Glu), TOPMed rs1948890889, REVEL 0.87, CADD 25.80
- E113G (p.Glu113Gly), NCI-TCGA TCGA novel, REVEL 0.60, CADD 24.00, Variant assessed as somatic; moderate impact.
- I114T (p.Ile114Thr), gnomAD rs1407509475, REVEL 0.72, CADD 25.80
- S118G (p.Ser118Gly), ExAC rs768282329, TOPMed rs768282329, gnomAD rs768282329, REVEL 0.41, CADD 19.40
- S118I (p.Ser118Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S118R (p.Ser118Arg), ExAC rs768282329, TOPMed rs768282329, gnomAD rs768282329
- N119D (p.Asn119Asp), TOPMed rs889679390, REVEL 0.46, CADD 23.10
- I121M (p.Ile121Met), ExAC rs748749875, gnomAD rs748749875
- I121T (p.Ile121Thr), gnomAD rs1198702808, REVEL 0.94, CADD 27.00
- I121V (p.Ile121Val), gnomAD rs1376431732, REVEL 0.35, CADD 21.50
- Q122L (p.Gln122Leu), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54383, Variant assessed as somatic; moderate impact.
- I126L (p.Ile126Leu), NCI-TCGA TCGA novel, REVEL 0.28, CADD 19.30, Variant assessed as somatic; moderate impact.
- I126M (p.Ile126Met), Ensembl rs1948855528, REVEL 0.31, CADD 16.20
- S128C (p.Ser128Cys), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99659, Variant assessed as somatic; moderate impact.
- K130* (p.Lys130Ter), TOPMed rs1948855386, CADD 37.00
- K130R (p.Lys130Arg), TOPMed rs1948855331, REVEL 0.90, CADD 24.20
- K130T (p.Lys130Thr), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54385, Variant assessed as somatic; moderate impact.
- Y131* (p.Tyr131Ter), ExAC rs763824951, TOPMed rs763824951, gnomAD rs763824951, CADD 33.00
- Y131H (p.Tyr131His), TOPMed rs1948855276
- V134L (p.Val134Leu), TOPMed rs1948855074
- N135D (p.Asn135Asp), TOPMed rs1948854978
- N135K (p.Asn135Lys), TOPMed rs1948854851, gnomAD rs1948854851, REVEL 0.78, CADD 25.90
- N135S (p.Asn135Ser), rs775107044, ClinGen CA6490130, ClinVar RCV004076702, ExAC rs775107044, REVEL 0.77, CADD 23.80, Uncertain significance, not specified
- R137I (p.Arg137Ile), rs1350039311, NCI-TCGA Cosmic COSV5438, cosmic curated COSV54383, gnomAD rs1350039311, REVEL 0.82, CADD 27.20, Variant assessed as somatic; moderate impact.
- L141F (p.Leu141Phe), ESP rs369678294, TOPMed rs369678294, gnomAD rs369678294, REVEL 0.56, CADD 15.10
- L141S (p.Leu141Ser), Ensembl rs1948854741
- K144N (p.Lys144Asn), TOPMed rs1326284306, gnomAD rs1326284306, REVEL 0.74, CADD 26.80
- N145D (p.Asn145Asp), ExAC rs759542652, gnomAD rs759542652, REVEL 0.72, CADD 27.30
- N145H (p.Asn145His), ExAC rs759542652, gnomAD rs759542652, REVEL 0.90, CADD 27.40
- A146G (p.Ala146Gly), ExAC rs776393999, gnomAD rs776393999, REVEL 0.86, CADD 27.80
- A146T (p.Ala146Thr), TOPMed rs1948854532
- R148C (p.Arg148Cys), NCI-TCGA Cosmic COSV9965, cosmic curated COSV99659, Variant assessed as somatic; moderate impact.
- R148H (p.Arg148His), cosmic curated COSV54387, ExAC rs770765348, gnomAD rs770765348, REVEL 0.81, CADD 23.80
- R148P (p.Arg148Pro), cosmic curated COSV10502, NCI-TCGA Cosmic COSV5438, Variant assessed as somatic; moderate impact.
- V149M (p.Val149Met), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54383, REVEL 0.89, CADD 26.10, Variant assessed as somatic; moderate impact.
- A153V (p.Ala153Val), ExAC rs746723932, gnomAD rs746723932, REVEL 0.32, CADD 22.60
- A154V (p.Ala154Val), ExAC rs779168277, TOPMed rs779168277, gnomAD rs779168277, REVEL 0.46, CADD 23.50
- G155R (p.Gly155Arg), gnomAD rs1435712429, REVEL 0.81, CADD 26.30
- N156H (p.Asn156His), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54386, Variant assessed as somatic; moderate impact.
- N156T (p.Asn156Thr), 1000Genomes rs539901221, ExAC rs539901221, gnomAD rs539901221, REVEL 0.78, CADD 26.00, Uncertain significance, not specified
- G158E (p.Gly158Glu), ExAC rs749411944, gnomAD rs749411944, REVEL 0.84, CADD 26.00
- G158R (p.Gly158Arg), Ensembl rs1948854105
- S159A (p.Ser159Ala), Ensembl rs1592070290
- F161L (p.Phe161Leu), TOPMed rs1042977981, gnomAD rs1042977981, REVEL 0.67, CADD 18.20
- H164Y (p.His164Tyr), NCI-TCGA TCGA novel, REVEL 0.56, CADD 23.10, Variant assessed as somatic; moderate impact.
- P165L (p.Pro165Leu), TOPMed rs1284086754, gnomAD rs1284086754, REVEL 0.93, CADD 24.60
- P165S (p.Pro165Ser), NCI-TCGA Cosmic COSV5438, cosmic curated COSV54388, Variant assessed as somatic; moderate impact.
- P165T (p.Pro165Thr), gnomAD rs920529318, REVEL 0.96, CADD 26.70
- F166L (p.Phe166Leu), rs563917550, ClinGen CA6490118, ClinVar RCV004257500, 1000Genomes rs563917550, REVEL 0.72, CADD 22.50, Uncertain significance, not specified
- W167C (p.Trp167Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S171N (p.Ser171Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E172K (p.Glu172Lys), gnomAD rs1486489380, REVEL 0.58, CADD 22.70
- E172V (p.Glu172Val), cosmic curated COSV10438, Ensembl rs1948853365
- G173S (p.Gly173Ser), gnomAD rs1948853315
- V177A (p.Val177Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- K181E (p.Lys181Glu), rs1020261536, ClinGen CA384330449, ClinVar RCV001261394, TOPMed rs1020261536, AlphaMissense 0.77, MetaLR 0.95, Uncertain significance, Intellectual disability
- K181Q (p.Lys181Gln), TOPMed rs1020261536, REVEL 0.84, AlphaMissense 0.77, Uncertain significance
- V183I (p.Val183Ile), Ensembl rs1948737794
- L184F (p.Leu184Phe), NCI-TCGA Cosmic COSV6726, Variant assessed as somatic; moderate impact.
- M185I (p.Met185Ile), TOPMed rs1948737577, gnomAD rs1948737577, REVEL 0.47, CADD 20.30
- M185V (p.Met185Val), ExAC rs766383573, gnomAD rs766383573, REVEL 0.57, CADD 19.20
- P186S (p.Pro186Ser), gnomAD rs1948737508, REVEL 0.74, CADD 25.30
- N188Y (p.Asn188Tyr), TOPMed rs1948737424
- A189T (p.Ala189Thr), Ensembl rs946624559
- G190W (p.Gly190Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q191* (p.Gln191Ter), gnomAD rs1370862900
- H194R (p.His194Arg), ExAC rs767300517, gnomAD rs767300517, REVEL 0.96, CADD 25.80
- H194Y (p.His194Tyr), rs1948736959, ClinGen CA384330288, ClinVar RCV004266084, Ensembl rs1948736959, REVEL 0.94, CADD 27.60, Uncertain significance, not specified
- S196C (p.Ser196Cys), ExAC rs761534785, gnomAD rs761534785, REVEL 0.97, CADD 27.70
- N197S (p.Asn197Ser), TOPMed rs1948736751
- I198M (p.Ile198Met), gnomAD rs1287858503, REVEL 0.39, CADD 17.10
- L201P (p.Leu201Pro), TOPMed rs1454141184, gnomAD rs1454141184, REVEL 0.48, CADD 22.40
- P204A (p.Pro204Ala), TOPMed rs1333523360
- G205R (p.Gly205Arg), Ensembl rs1853570491, REVEL 0.88, CADD 26.00
- G205W (p.Gly205Trp), Ensembl rs1853570491, REVEL 0.94, CADD 28.50
- C206Y (p.Cys206Tyr), ExAC rs769903343, gnomAD rs769903343, REVEL 0.86, CADD 26.40
- K207Q (p.Lys207Gln), NCI-TCGA Cosmic COSV6727, Variant assessed as somatic; moderate impact.
- V209M (p.Val209Met), Ensembl rs1043844974, REVEL 0.88, CADD 32.00
- A211P (p.Ala211Pro), NCI-TCGA Cosmic COSV6727, Variant assessed as somatic; moderate impact.
- A211V (p.Ala211Val), gnomAD rs1186332516, REVEL 0.52, CADD 22.70
- N213S (p.Asn213Ser), TOPMed rs1948730627
- T216I (p.Thr216Ile), gnomAD rs1281683856, REVEL 0.97, CADD 25.40
- S217R (p.Ser217Arg), ExAC rs747029100, gnomAD rs747029100, REVEL 0.70, CADD 24.10
- W218* (p.Trp218Ter), NCI-TCGA Cosmic COSV1011, CADD 39.00, Variant assessed as somatic; high impact.
- T221A (p.Thr221Ala), TOPMed rs554544073, gnomAD rs554544073, REVEL 0.56, CADD 20.60
- T221S (p.Thr221Ser), TOPMed rs554544073, gnomAD rs554544073, REVEL 0.40, CADD 18.20
- M224I (p.Met224Ile), ExAC rs773915098, gnomAD rs773915098, REVEL 0.87, CADD 27.40
- M224T (p.Met224Thr), TOPMed rs1290983158, gnomAD rs1290983158, REVEL 0.88, CADD 26.40
- M224V (p.Met224Val), gnomAD rs1308957478, REVEL 0.88, CADD 25.60
- S227G (p.Ser227Gly), gnomAD rs1355795763, REVEL 0.80, CADD 24.10
- S227N (p.Ser227Asn), ExAC rs772702197, TOPMed rs772702197, gnomAD rs772702197, REVEL 0.62, CADD 23.40
- S228A (p.Ser228Ala), ExAC rs748567988, TOPMed rs748567988, gnomAD rs748567988, REVEL 0.32, CADD 23.20
- S228F (p.Ser228Phe), rs868019660, ClinGen CA234839159, ClinVar RCV004283117, Ensembl rs868019660, REVEL 0.53, CADD 25.60, Uncertain significance, not specified
- S228T (p.Ser228Thr), ExAC rs748567988, TOPMed rs748567988, gnomAD rs748567988, REVEL 0.35, CADD 23.00
- Y229C (p.Tyr229Cys), NCI-TCGA Cosmic COSV6727, Variant assessed as somatic; moderate impact.
- R230* (p.Arg230Ter), TOPMed rs1239360287, gnomAD rs1239360287, CADD 36.00
- R230Q (p.Arg230Gln), TOPMed rs980116007, gnomAD rs980116007, REVEL 0.34, CADD 20.30
- D232G (p.Asp232Gly), NCI-TCGA Cosmic COSV6726, REVEL 0.77, CADD 27.40, Variant assessed as somatic; moderate impact.
- V233A (p.Val233Ala), NCI-TCGA TCGA novel, REVEL 0.73, CADD 27.90, Variant assessed as somatic; moderate impact.
- G236* (p.Gly236Ter), ExAC rs769018673, gnomAD rs769018673, CADD 39.00
- G236R (p.Gly236Arg), ExAC rs769018673, gnomAD rs769018673, REVEL 0.94, CADD 32.00
- V239I (p.Val239Ile), TOPMed rs1948722475, REVEL 0.69, CADD 25.60
- A245E (p.Ala245Glu), Ensembl rs1592064105, REVEL 0.89, CADD 28.10
Public ITPR2 analysis runs
- ITPR2 analysis run — ITPR2 (2,736 variants) — completed 2026-09-02